ResMed | RMD - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Ansell USD 468.9M 53.1M 2025-12
Artivion USD 92.7M 8.86M 2026-03
AtriCure USD 73.19M 8.33M 2026-03
Baxter International USD 3.69B 723M 2026-03
Cochlear AUD 558.9M 43.4M 2025-12
Cooper Companies USD 1.8B 209M 2026-03
CSL USD 4.61B 207M 2025-12
Dexcom USD 2.22B 81.3M 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Fisher Paykel Healthcare NZD 471.3M 29.1M 2025-12
Globus Medical USD 482.46M 16.04M 2026-03
Haemonetics USD 282.6M 257.27M 2026-03
Idexx Laboratories USD 1.3B 151.04M 2026-03
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 687.5M 7.4M 2026-03
Integra LifeSciences USD 346.85M 109.14M 2026-03
Intuitive Surgical USD 2.51B 3.2M 2026-03
Masimo USD 325.4M 46.2M 2026-03
Medtronic USD 9.5B 440M 2025-12
Philips EUR 7.43B 78M 2026-03
Ramsay Health Care AUD 3.95B 514.2M 2025-12
ResMed USD 1.35B 103.1M 2026-03
Sigma Healthcare AUD 1.7B 1.33B 2025-12
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Steris USD 1.14B 222.7M 2026-03
Teleflex USD 728.05M 33.98M 2026-03
Thermo Fisher Scientific USD 14.62B 568M 2026-03